Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression (Q30659312)

26 June 2017

1 reference

title

Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression (English)

1 reference

26 June 2017

0 references

Simon JH

1

1 reference

26 June 2017

publication date

1 January 2001

1 reference

26 June 2017

1 reference

26 June 2017

volume

15

1 reference

26 June 2017

issue

6

1 reference

26 June 2017

page(s)

427-436

1 reference

Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.

26 June 2017

cites work

1 reference

12 December 2020

Primary progressive multiple sclerosis

1 reference

12 December 2020

The distribution of plaques in the cerebrum in multiple sclerosis

1 reference

12 December 2020

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

1 reference

12 December 2020

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

1 reference

12 December 2020

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

1 reference

12 December 2020

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis

1 reference

12 December 2020

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis

1 reference

12 December 2020

Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability

1 reference

12 December 2020

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

12 December 2020

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

1 reference

12 December 2020

Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators

1 reference

12 December 2020

Detection of ventricular enlargement in patients at the earliest clinical stage of MS

1 reference

12 December 2020

Total brain N-acetylaspartate: a new measure of disease load in MS.

1 reference

12 December 2020

Brain and spinal cord atrophy in multiple sclerosis

1 reference

12 December 2020

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

12 December 2020

Magnetization transfer imaging to monitor clinical trials in multiple sclerosis.

1 reference

12 December 2020

One year follow up study of primary and transitional progressive multiple sclerosis

1 reference

12 December 2020

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

A Wallerian degeneration pattern in patients at risk for MS.

1 reference

12 December 2020

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

1 reference

12 December 2020

Corpus callosum in multiple sclerosis

1 reference

12 December 2020

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

12 December 2020

Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers.

1 reference

12 December 2020

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment

1 reference

12 December 2020

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

1 reference

12 December 2020

Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis

1 reference

12 December 2020

Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis.

1 reference

12 December 2020

From enhancing lesions to brain atrophy in relapsing MS.

1 reference

12 December 2020

Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis

1 reference

12 December 2020

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

1 reference

12 December 2020

Primary and transitional progressive MS: a clinical and MRI cross-sectional study

1 reference

12 December 2020

The morbid anatomy of the demyelinative disease

1 reference

12 December 2020

The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis.

1 reference

12 December 2020

The fine structure of chronically active multiple sclerosis plaques

1 reference

12 December 2020

Spinal cord atrophy and disability in multiple sclerosis

1 reference

12 December 2020

Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment

1 reference

12 December 2020

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

12 December 2020

Neuropsychology of multiple sclerosis

1 reference

12 December 2020

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Spinal cord atrophy and disability in MS: A longitudinal study

1 reference

12 December 2020

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions

1 reference

12 December 2020

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis

1 reference

12 December 2020

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

1 reference

12 December 2020

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

A spinal cord MRI study of benign and secondary progressive multiple sclerosis

1 reference

12 December 2020

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

12 December 2020

A Longitudinal Magnetic Resonance Imaging Study of the Cervical Cord in Multiple Sclerosis

1 reference

12 December 2020

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

12 December 2020

Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis

1 reference

12 December 2020

10.2165/00023210-200115060-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

26 June 2017

1018701140

0 references

1 reference